title: Quantitative proteomic analysis reveals effects of epidermal growth factor receptor (EGFR) on invasion-promoting proteins secreted by glioblastoma cells.
abstract: Glioblastoma multiforme is a highly invasive and aggressive brain tumor with an invariably poor prognosis. The overexpression of epidermal growth factor receptor (EGFR) is a primary influencer of invasion and proliferation in tumor cells and the constitutively active EGFRvIII mutant, found in 30-65% of Glioblastoma multiforme, confers more aggressive invasion. To better understand how EGFR contributes to tumor aggressiveness, we investigated the effect of EGFR on the secreted levels of 65 rationally selected proteins involved in invasion. We employed selected reaction monitoring targeted mass spectrometry using stable isotope labeled internal peptide standards to quantity proteins in the secretome from five GBM (U87) isogenic cell lines in which EGFR, EGFRvIII, and/or PTEN were expressed. Our results show that cell lines with EGFR overexpression and constitutive EGFRvIII expression differ remarkably in the expression profiles for both secreted and intracellular signaling proteins, and alterations in EGFR signaling result in reproducible changes in concentrations of secreted proteins. Furthermore, the EGFRvIII-expressing mutant cell line secretes the majority of the selected invasion-promoting proteins at higher levels than other cell lines tested. Additionally, the intracellular and extracellular protein measurements indicate elevated oxidative stress in the EGFRvIII-expressing cell line. In conclusion, the results of our study demonstrate that EGFR signaling has a significant effect on the levels of secreted invasion-promoting proteins, likely contributing to the aggressiveness of Glioblastoma multiforme. Further characterization of these proteins may provide candidates for new therapeutic strategies and targets as well as biomarkers for this aggressive disease.
authors.affiliation: From the ‡Institute for Systems Biology, 401 Terry Ave N, Seattle, Washington, 98109.
authors.forename: Vineet
authors.initials: V
authors.lastname: Sangar
authors.affiliation: From the ‡Institute for Systems Biology, 401 Terry Ave N, Seattle, Washington, 98109.
authors.forename: Cory C
authors.initials: CC
authors.lastname: Funk
authors.affiliation: From the ‡Institute for Systems Biology, 401 Terry Ave N, Seattle, Washington, 98109.
authors.forename: Ulrike
authors.initials: U
authors.lastname: Kusebauch
authors.affiliation: From the ‡Institute for Systems Biology, 401 Terry Ave N, Seattle, Washington, 98109.
authors.forename: David S
authors.initials: DS
authors.lastname: Campbell
authors.affiliation: From the ‡Institute for Systems Biology, 401 Terry Ave N, Seattle, Washington, 98109.
authors.forename: Robert L
authors.initials: RL
authors.lastname: Moritz
authors.affiliation: From the ‡Institute for Systems Biology, 401 Terry Ave N, Seattle, Washington, 98109 nprice@systemsbiology.org.
authors.forename: Nathan D
authors.initials: ND
authors.lastname: Price
mesh_terms: D045744:Cell Line, Tumor; D066246:ErbB Receptors / Q000378:metabolism*; D015972:Gene Expression Regulation, Neoplastic; D005909:Glioblastoma / Q000378:metabolism* / Q000473:pathology*; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000378:metabolism*; D009361:Neoplasm Invasiveness; D051059:PTEN Phosphohydrolase / Q000378:metabolism; D040901:Proteomics / Q000379:methods*; D015398:Signal Transduction
chemical_list: D047908:Intracellular Signaling Peptides and Proteins; C410723:epidermal growth factor receptor VIII; C512478:EGFR protein, human; D066246:ErbB Receptors; D051059:PTEN Phosphohydrolase; C494929:PTEN protein, human